Thor Medical ASA
Oslo Stock Exchange TRMED.OL
Thor Medical ASA EPS (Diluted) for the year ending December 31, 2023: USD -0.00
Thor Medical ASA EPS (Diluted) is USD -0.00 for the year ending December 31, 2023. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
-
Thor Medical ASA EPS (Diluted) for the year ending December 31, 2021 was USD -0.53, a 23.66% change year over year.
-
Thor Medical ASA EPS (Diluted) for the year ending December 31, 2020 was USD -0.69.
Key data
| Date | EPS (Diluted) | Shares (Diluted, Weighted) | Shares (Basic, Weighted) | Revenue |
|---|
Market news
Loading...
Oslo Stock Exchange: TRMED.OL
| CEO | Mr. Jasper Kurth |
| IPO Date | March 23, 2015 |
| Location | Norway |
| Headquarters | Karenslyst allé 9C |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email